glp 2 vs tirzepatide Semaglutide for Weight Loss: Which is Better? Tirzepatide | GLP-1R and GIPR

In June 2024, the FDA officially approved tirzepatide for the treatment of obesity-associated OSAS, marking the first GLP-1based therapy worldwide to receive this indication (16)

Call now to schedule your appointment and begin your transformation no risks, just results.

Know the risk is low but not zero

This form of Zepbound comes in a vial, which means patients must use a disposable syringe to inject it, rather than a self-injectable pen

For those seeking support in their weight loss journey, Tirzepatide has emerged as a promising option, transforming how people approach weight management

Dizziness Some people experience dizziness while on Mounjaro